The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III trial of erlotinib vs. docetaxel in patients with advanced squamous cell non-small cell lung cancer (SqNSCLC) failing first line platinum based doublet chemotherapy stratified by VeriStrat Good vs VeriStrat Poor: The European Thoracic Oncology Platform (ETOP) EMPHASIS trial.
 
Solange Peters
No Relationships to Disclose
 
Egbert F. Smit
No Relationships to Disclose
 
Urania Dafni
No Relationships to Disclose
 
Santiago Ponce Aix
No Relationships to Disclose
 
Bartomeu Massuti
No Relationships to Disclose
 
Oliver Gautschi
No Relationships to Disclose
 
Linda Coate
No Relationships to Disclose
 
Ana López Martín
No Relationships to Disclose
 
Robbert van Heemst
No Relationships to Disclose
 
Thierry Berghmans
Research Funding - AstraZeneca; Novartis; Peregrine Pharmaceuticals; Pfizer
 
Peter Meldgaard
No Relationships to Disclose
 
Manuel Cobo Dols
No Relationships to Disclose
 
Javier Garde Noguera
No Relationships to Disclose
 
Irene Claudia Floriani
No Relationships to Disclose
 
Marie Kassapian
No Relationships to Disclose
 
Yojena Chittazhathu Kurian Kuruvilla
No Relationships to Disclose
 
Adriana Gasca-Ruchti
No Relationships to Disclose
 
Christoph Zielinski
No Relationships to Disclose
 
Vanesa Gregorc
No Relationships to Disclose
 
Rolf A. Stahel
Consulting or Advisory Role - Abbott Diagnostics; Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech; Lilly; Merck Sharp & Dohme; Novartis; Puma Biotechnology; Roche Pharma AG
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Roche Pharma AG